← Leaderboards
Nicholas J Mantis
Children'S Hospital Boston
$20,156,428
Attributed
$21,401,744
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$21,401,744 · 14
By mechanism
N01$10,284,341 · 1
R01$6,022,426 · 2
U01$2,570,126 · 1
R21$1,732,365 · 4
R03$452,684 · 3
K01$301,239 · 1
Top collaborators
- Lynn Bry6 shared
- Jeongmin Song2 shared
- Joseph Thomas Wade2 shared
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesEpitopesInfectionBaseAntigensIn VitroImmunityLaboratoriesMediatingPathogenSurfaceAntibody ResponseMouse ModelSerumRicinVaccinesImmunoglobulin APreventProductionCellsImmunoglobulin GNew YorkAffectLink
Grant awards (41)
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection$1,865,211
N01 · FY2023 · AI · contact PI
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology$824,595
U01 · FY2023 · CA · contact PI
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection$1,887,202
N01 · FY2022 · AI · contact PI
Tickborne Disease: B cell epitope discovery and mechanisms of antibody Protection$1,123,255
N01 · FY2022 · AI · contact PI
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology$592,301
U01 · FY2022 · CA · contact PI
Leveraging a transcription regulatory network to understand Salmonella invasion of host epithelial cells$209,136
R21 · FY2022 · AI
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection$1,846,478
N01 · FY2021 · AI · contact PI
Leveraging a transcription regulatory network to understand Salmonella invasion of host epithelial cells$181,045
R21 · FY2021 · AI
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection$1,901,409
N01 · FY2020 · AI · contact PI
High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology$1,153,230
U01 · FY2020 · CA · contact PI
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines$519,830
R01 · FY2020 · AI · contact PI
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection$1,660,786
N01 · FY2019 · AI · contact PI
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines$519,830
R01 · FY2019 · AI · contact PI
Neutralizing Antibodies to Typhoid Toxin$78,965
R03 · FY2019 · AI
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines$1,034,414
R01 · FY2018 · AI · contact PI
Neutralizing Antibodies to Typhoid Toxin$92,878
R03 · FY2018 · AI
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines$1,057,355
R01 · FY2017 · AI · contact PI
Mechanisms of IgA - mediated immunity to Vibrio cholerae$184,248
R21 · FY2017 · AI · contact PI
Mechanisms of IgA - mediated immunity to Vibrio cholerae$46,759
R21 · FY2017 · AI · contact PI
Development of a Preclinical Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines$962,389
R01 · FY2016 · AI · contact PI
Mechanisms of IgA - mediated immunity to Vibrio cholerae$220,265
R21 · FY2016 · AI · contact PI
Mechanisms of IgA-mediated immunity to Salmonella$73,122
R03 · FY2016 · AI · contact PI
Mechanisms of IgA-mediated immunity to Salmonella$72,211
R03 · FY2015 · AI · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$373,283
R01 · FY2013 · HD · contact PI
Ricin toxin: Neutralizing antibodies and vaccine design$67,754
R03 · FY2013 · AI · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$411,044
R01 · FY2012 · HD · contact PI
Ricin toxin: Neutralizing antibodies and vaccine design$67,754
R03 · FY2012 · AI · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$412,584
R01 · FY2011 · HD · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$33,051
R01 · FY2011 · HD · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$349,296
R01 · FY2010 · HD · contact PI
Mannose Receptor in Ricin Pathogenesis$178,811
R21 · FY2010 · AI · contact PI
MECHANISMS OF SECRETORY IGA MEDIATED IMMUNITY TO ENTERIC PATHOGENS$16,220
P41 · FY2010 · RR · contact PI
Epithelial Glycoconjugates as Barriers against Enteric Infections$349,350
R01 · FY2009 · HD · contact PI
Mannose Receptor in Ricin Pathogenesis$176,729
R21 · FY2009 · AI · contact PI
MECHANISMS OF SECRETORY IGA MEDIATED IMMUNITY TO ENTERIC PATHOGENS$22,343
P41 · FY2009 · RR · contact PI
Gastrointestinal Immunity to Ricin$275,224
R21 · FY2005 · AI
Gastrointestinal Immunity to Ricin$186,185
R21 · FY2004 · AI
Gastrointestinal Immunity to Ricin$73,963
R21 · FY2004 · AI
IgA-Antigen Uptake by Peyer's Patch M cells$120,879
K01 · FY2003 · DK
IgA-Antigen Uptake by Peyer's Patch M cells$92,880
K01 · FY2002 · DK
IgA-Antigen Uptake by Peyer's Patch M cells$87,480
K01 · FY2001 · DK